6286-46-0

Basic information

• Product Name: 2-BROMO-4,5-DIMETHOXYBENZOIC ACID
• Synonyms: 2-BROMO-4,5-DIMETHOXYBENZOIC ACID;6-BROMOVERATRIC ACID;6-BROMO-3,4-DIMETHOXYBENZOIC ACID;RARECHEM AL BE 0015;2-Bromo-4,5-dimethoxybenzoic acid,97%;Nsc10074;441074_ALDRICH;Benzoic acid, 2-bromo-4,5-dimethoxy-
• CAS NO: 6286-46-0
• Molecular Formula: C₉H₉BrO₄
• Molecular Weight: 261.07
• Product Categories: Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts;Aromatics Compounds;Aromatics
• Mol File: 6286-46-0.mol

Chemical Properties

• Melting Point: 188-190 °C(lit.)
• Boiling Point: 337.6 °C at 760 mmHg
• Flash Point: 158 °C
• Appearance: White to cream or yellow/Powder
• Density: 1.571 g/cm³
• Vapor Pressure: 4.05E-05mmHg at 25°C
• Refractive Index: 1.566
• Storage Temp.: Room temperature.
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• PKA: 3.00±0.10(Predicted)
• CAS DataBase Reference: 2-BROMO-4,5-DIMETHOXYBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-4,5-DIMETHOXYBENZOIC ACID(6286-46-0)
• EPA Substance Registry System: 2-BROMO-4,5-DIMETHOXYBENZOIC ACID(6286-46-0)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 6286-46-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-4,5-dimethoxybenzoic acid is used as a starting material for the synthesis of norathyriol, a compound with potential pharmaceutical applications. Norathyriol is known for its bioactivity and can be further processed to create drugs with therapeutic benefits.
Used in Nutraceutical Industry:
In the nutraceutical industry, 2-Bromo-4,5-dimethoxybenzoic acid serves as a precursor for the synthesis of urolithins, a group of metabolites derived from ellagic acid found in pomegranates and other fruits. Urolithins have gained attention for their potential health benefits, including antioxidant and anti-inflammatory properties, making them valuable components in dietary supplements and functional foods.

InChI:InChI=1/C9H9BrO4/c1-13-7-3-5(9(11)12)6(10)4-8(7)14-2/h3-4H,1-2H3,(H,11,12)

Upstream product

• 7732-18-5 water 
• 7726-95-6 bromine 
• 93-07-2 Veratric acid 
• 67-66-3 chloroform 
• 58262-60-5 2,3',4,4',6-pentamethoxybenzophenone 
• 272766-46-8 1-allyl-2-bromo-4,5-dimethoxybenzene 
• 26759-46-6 methyl 2-amino-4,5-dimethoxybenzoate 
• 619-04-5 3,4-dimethylbenzoic acid 
• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 26791-93-5 methyl 4,5-dimethoxy-2-nitrobenzoate 
• 494-99-5 1,2-dimethoxy-4-methylbenzene 
• 60632-40-8 6-bromovanillin 
• 2150-38-1 methyl 3,4-dimethoxybenzoate 
• 52806-46-9 1-bromo-4,5-dimethoxy-2-methylbenzene 

Downstream Products

• 17667-32-2 methyl 6-bromo-3,4-dimethoxybenzoate 
• 55171-61-4 2-bromo-4,5-dimethoxybenzoyl chloride 
• 121031-19-4 benzyl 2-bromo-4,5-dimethoxybenzoate 
• 170709-79-2 (E)-N-(3',4'-dimethoxystyryl)-2-bromo-4,5-dimethoxybenzamide 
• 128604-36-4 2-Bromo-4,5-dimethoxy-N-[2-(4-methoxy-phenyl)-ethyl]-benzamide 
• 1038556-36-3 2-bromo-4,5-dimethoxy-N-[3-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-ylcarbamoyl)-benzyl]-benzamide 
• 2859-78-1 4-Bromoveratrole 
• 5722-93-0 2-hydroxy-4,5-dimethoxybenzoic acid 
• 877997-98-3 2-hydroxy-4,5-dimethoxybenzoic acid phenyl ester 
• 877997-99-4 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylic acid methyl ester 
• 1569640-33-0 (E)-2-(ethoxycarbonyl)vinyl 2-bromo-4,5-dimethoxybenzoate 
• 1610724-78-1 2-bromo-N-(4-fluorophenyl)-4,5-dimethoxybenzamide 
• 1610724-79-2 2-bromo-N-(4-chlorophenyl)-4,5-dimethoxybenzamide 
• 1236228-55-9 2-bromo-N-(4-methylphenyl)-4,5-dimethoxybenzamide 

Relevant articles and documents

Synthesis of 4-ethyl-5-methyl-5,6-dihydrophenanthridine-8,9-diol as the key intermediate of potent agonists of the Wnt signalling pathway

The synthesis of 4-ethyl-5-methyl-5,6-dihydro-phenanthridine-8,9-diol as the key intermediate of a series of potent Wnt signalling pathway agonists is reported. This synthesis features a consecutive aryl-aryl and N-aryl coupling, leading to 4-ethyl-5-meth

Tandem copper catalyzed regioselectiveN-arylation-amidation: synthesis of angularly fused dihydroimidazoquinazolinones and the anticancer agent TIC10/ONC201

Herein, we present a copper-catalyzed tandem reaction of 2-aminoimidazolines andortho-halo(hetero)aryl carboxylic acids that causes the regioselective formation of angularly fused tricyclic 1,2-dihydroimidazo[1,2-a]quinazolin-5(4H)-one derivatives. The reaction involved in the construction of the core six-membered pyrimidone moiety proceededviaregioselectiveN-arylation-condensation. The presented protocol been successfully applied to accomplish the total synthesis of TIC10/ONC201, which is an active angular isomer acting as a tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL): a sought after anticancer clinical agent.

THIOXANTHONE DERIVATIVES, COMPOSITION COMPRISING THE SAME AND PATTERN FORMING METHOD COMPRISING SAID COMPOSITION

Latent photoinitiator compounds are described, as well as compositions containing such compounds and their uses in photoinitated methods for producing photoresist structures.

COMPOUND FOR TREATMENT OR PREVENTION OF OBESITY OR DISEASES RELATED TO OBESITY, AND APPLICATION THEREOF

A compound for treatment or prevention of obesity or diseases related to obesity, and an application thereof. Specifically, provided are a compound as represented by formula I, or a pharmaceutically-acceptable salt thereof, and a pharmaceutical compositio

METHOD FOR PRODUCING 2-HALOGENATED BENZOIC ACIDS

The purpose of the present invention is to provide a method for producing 2-halogenated benzoic acids, the method imparting high regioselectivity (high selectivity) and having a shorter reaction time than does the conventional reaction. This method for producing 2-halogenated benzoic acids, in order to achieve the above purpose, is characterized in that benzoic acids and a halogenating agent are reacted in the presence of an alkaline compound, making it possible to highly selectively obtain 2-halogenated benzoic acids.

Urolithin C, a gut metabolite of ellagic acid, induces apoptosis in PC12 cells through a mitochondria-mediated pathway

Urolithins (Uros), metabolites of ellagitannins (ET) and ellagic acid (EA) produced by gut microbiota, showed better bioavailability and extensive bioactivity, and were considered as the active compounds responsible for the health benefits exerted by ET-containing foodstuffs. Here, we chemically synthesized three Uros including Uros A, B, and C and compared their anti-proliferative activities with that of EA in PC12 cells. MTT assay showed that EA significantly promoted, while Uros significantly inhibited the proliferation of PC12 cells, among which UroC showed the strongest anti-proliferation. UroC treatment actively increased the lactate dehydrogenase (LDH) release and lipid peroxidation malondialdehyde (MDA), stimulated reactive oxygen species (ROS) formation and mitochondrial membrane depolarization, and caused calcium dyshomeostasis. Furthermore, flow cytometry analysis showed that UroC treatment induced apoptosis and S phase cell cycle arrest with increasing UroC concentrations. Consequently, UroC also induced imbalance in the Bcl-2/Bax ratio, which triggered the caspase cascade, thereby shifting the balance in favor of apoptosis, as evidenced by western blotting and real-time PCR. These observations indicated that UroC possessed significantly different anti-proliferation activities from EA, and actively induced cell apoptosis through a mitochondria-mediated pathway.

Phenanthridine Derivatives, Preparation Methods and Uses Thereof

The present invention relates to the pharmaceutical field, in particular to a phenanthridine derivative as shown in general formula (1) a pharmaceutical composition comprising the derivative, its preparation method, and its uses in manufacture of a medica

Efficient and convenient copper-free Pd(OAc)2/Ruphos-catalyzed Sonogashira coupling in the preparation of corfin analogues

The Sonogashira coupling reaction of 3-chloro-1H-isochromen-1-one and terminal alkynes, in the presence of catalytic system-Pd(OAc)2/Ruphos, Et3N base, and tetrahydrofuran solvent under aqueous conditions, provided novel 3-(alkynyl)-

Palladium catalyzed Suzuki Miyaura cross coupling of 3-chloroisochromen-1-one: Synthesis of glomellin and reticulol analogues

A facile protocol has been developed for a series of 3-substituted isochromen-1-ones utilizing Suzuki coupling strategy. The reaction of 3-chloroisochromen-1one, 1 with different boronic acids utilizing PdCl2(PPh3)2-Ruphos catalytic system gave diversified 3-substituted isochromen-1-ones in excellent yields. The methodology has been utilized in the synthesis of glomellin and reticulol analogues.

Efficient copper-free Pd(OAc)2/Ruphos-catalyzed Sonogashira coupling in the preparation of 3′-hydroxycorfin and gymnopalynes A analogues

An efficient method involving copper-free Pd(OAc)2/Ruphos-catalyzed Sonogashira coupling strategy for a variety of 3-alkynyl isochromen-1-ones has been developed. Sonogashira coupling in the presence of catalytic system - Pd(OAc)2/Ruphos, Et3N base, and tetrahydrofuran solvent under aqueous and room temperature conditions, provided novel 3-(alkynyl)-1H-isochromen-1-ones in excellent yields. The methodology has also been extended toward natural isochromen-1-one-3′-hydroxycorfin and gymnopalynes A analogues.